Podcasts
February 23, 2022

Harini Bupathi Featured Guests on Business of Pharmacy Podcast

Frier Levitt attorney Harini Bupathi, Esq. were featured guests on the Business of Pharmacy Podcast, hosted by Mike Koelzer. Listen to the podcast to hear them discuss PBM audits of pharmacies and recent state laws below.

Related People

Harini Bupathi

Topics

Pharmacy Law
Defending Pharmacies in PBM Audits
Life Sciences
Community, Retail Pharmacies
Antitrust Tools for Combating PBM Abuse
Podcast

Call Us Now

Harini Bupathi Featured Guests on Business of Pharmacy Podcast

Arizona’s Withdrawn GLP-1 Compounding Bill Signals Increased Scrutiny

PBMs Are Targeting Alabama Hospitals with Discriminatory Networks: What 340B Covered Entities Need to Know

A.J. Barbarito Featured in MedCity News: “It Took Years for Congress to Enact PBM Transparency, Delinking. What About Vertical Integration?”

Plan Sponsor Alert: Recent ERISA Decisions Increase Employer Liability Risk for Excessive Fees Paid to Vendors, Brokers, and Service Providers, Including PBMs

Arizona Board of Pharmacy Amendments: Enforcement Caps, Board Continuation, and Ownership Changes

The Peptide Landscape Is Shifting: What Secretary Kennedy’s Joe Rogan Interview Could Mean for the Compounding Industry

From Crackdown to Collaboration: FDA Warning Letters and the Hims-Novo Nordisk Deal Signal a New Era for Compounded GLP-1 Drugs

FDA Crackdown on Telehealth Advertising: What Your Company Needs to Know About Compounded Drug Marketing Compliance

Harini Bupathi Featured Guests on Business of Pharmacy Podcast

Related Insights

Arizona’s Withdrawn GLP-1 Compounding Bill Signals Increased Scrutiny

PBMs Are Targeting Alabama Hospitals with Discriminatory Networks: What 340B Covered Entities Need to Know

A.J. Barbarito Featured in MedCity News: “It Took Years for Congress to Enact PBM Transparency, Delinking. What About Vertical Integration?”

Plan Sponsor Alert: Recent ERISA Decisions Increase Employer Liability Risk for Excessive Fees Paid to Vendors, Brokers, and Service Providers, Including PBMs

Arizona Board of Pharmacy Amendments: Enforcement Caps, Board Continuation, and Ownership Changes

The Peptide Landscape Is Shifting: What Secretary Kennedy’s Joe Rogan Interview Could Mean for the Compounding Industry

From Crackdown to Collaboration: FDA Warning Letters and the Hims-Novo Nordisk Deal Signal a New Era for Compounded GLP-1 Drugs

FDA Crackdown on Telehealth Advertising: What Your Company Needs to Know About Compounded Drug Marketing Compliance